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doi:10.1016/j.jtcvs.2005.10.041bjective: In some respects, outcome reporting in valvular surgery has been ham-
ered by focusing on specific populations, reluctance to publish high-risk sub-
roups, and possibly skewed or inadequate samples. The goal of this study was to
valuate risk factors for operative mortality comprehensively across the entire
pectrum of cardiac valvular procedures over the past decade.
ethods: All 409,904 valve procedures in the Society of Thoracic Surgeons
atabase performed between 1994 and 2003 were assessed, and Society of Thoracic
urgeons preoperative and operative variables were related to operative mortality by
sing a multivariable logistic regression model. Data were greater than 95% com-
lete, and the relative importance of relevant risk factors was determined by ranking
dds ratios. The analysis had a high predictive power, with a C statistic of 0.735.
esults: In the model, 19 variables independently influenced operative mortality (all
 .01). The most significant was nonelective (acute) presentation (odds ratios,
.11), followed by advanced age (odds ratios, 1.88), reoperation (odds ratios, 1.61),
ndocarditis (odds ratios, 1.59), and coronary disease (odds ratios, 1.58). Generally,
alve replacement was associated with higher mortality than repair (odds ratios,
.52). Overall, female gender was very important (odds ratios, 1.37), and earlier
ear of operation increased risk (odds ratios, 1.34), implying improving outcomes
ver time. Although any single comorbidity, on average, was only moderately
ontributory (odds ratios, 1.19), specific comorbidities, such as renal failure, or
ultiple comorbidities in a given patient could be very significant. Aortic root
econstruction carried the highest risk (odds ratios, 2.78), followed by tricuspid
alve surgery (odds ratios, 2.26), multiple valve procedures (odds ratios, 2.06), and
hen isolated mitral (odds ratios, 1.47), pulmonic (odds ratios, 1.29), and aortic
reference procedure) operations. Reduced ejection fraction and severity of valve
esion were relatively less important (odds ratios, 1.34 and 0.83, respectively).
onclusions: These data illustrate the significance of acute presentation in deter-
ining operative risk, and earlier surgical intervention under elective conditions
ight be emphasized for all types of significant valve lesions. Because aortic root
econstruction doubles mortality compared with simple aortic valve procedures, root
eplacement should be reserved for specific root pathology. Finally, issues related to
eoperation, endocarditis, valve repair, gender, and the various procedures deserve
ore detailed examination.
cientific understanding of how baseline patient variables influence operative
mortality in cardiac valvular surgery may have been limited by several
factors. Most studies have reviewed small series from single centers and have
ocused on highly specific and usually low-risk subgroups. Complex valvular
rocedures are not available in sufficient numbers in most hospitals to allow a
omprehensive analysis, and because the more complicated cases tend to have
The Journal of Thoracic and Cardiovascular Surgery ● Volume 131, Number 3 547
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CDigher operative mortalities, many investigators may have
een reluctant to publish high-mortality data from complex
ategories. Confusion occasionally has existed regarding
atient classification, and analyses sometimes have been so
etailed as to limit clinical utility. Finally, results tend to
hange over time, and data regarding contemporary out-
omes, as well as how prognosis has evolved in recent
ears, would be useful. As a result of all these issues,
urrent prognostic effects of adverse baseline characteris-
ics, such as advanced age, left ventricular (LV) dysfunc-
ion, and acute presentation, are poorly understood, espe-
ially as related to the entire spectrum of valve surgery. For
xample, one recent series of mitral valve repairs for isch-
mic mitral regurgitation found that severe LV dysfunction
as no longer a prognostic factor.1 Such a finding could be
purious because of limited sample size, focus on one pro-
edure, or assessment from a single center, the results of
hich might not be representative. The goal of the present
tudy was to clarify this topic by generating a simple but
omprehensive risk factor analysis of operative mortality in
he entire Society of Thoracic Surgeons (STS) valve surgery
egistry. Because many centers are represented and because
ll valvular procedures are present in ample numbers, it was
nticipated that a more complete view of contemporary
alve surgery might be obtained.
atients and Methods
ata Source
he STS national database was established in 1989 by North
merican heart surgeons to collect and assess cardiac surgical
esults in a valid and consistent manner.2,3 The STS database
urrently records the results of more than 70% of US adult cardiac
urgical procedures annually. Clinical patient data are entered at
ites using uniform definitions and certified software systems.
etailed definitions for preoperative risk factors, as well as com-
lications, have been established by the STS and can be viewed
nline (http://www.sts.org). Data from individual centers are har-
ested semiannually and sent to the STS data warehouse and
nalysis center at the Duke Clinical Research Institute. A series of
ata quality checks are performed before data are aggregated into
he national sample. Since 1994, the variables entered and defini-
ions used have been changed in minor ways, but for this study,
onsistent baseline variables were available in every category for
he entire 10-year period, with an overall missing rate of 3.85%.
he frequency of missing data ranged from 0.0% for patient
Abbreviations and Acronyms
IABP intra-aortic balloon pumping
LV  left ventricular
OR  odds ratio
STS  Society of Thoracic Surgeonsender to 16.5% for ejection fraction. The accuracy and compa- g
48 The Journal of Thoracic and Cardiovascular Surgery ● Marcability of STS results have been confirmed by comparison with
ther mandatory and audited cardiac databases.4
atient Population
he population for this study included all 409,904 cardiac valvular
rocedures in the STS database recorded over the 10-year period
etween January 1, 1994, and December 31, 2003. From this total,
22 procedures were omitted for “resection of sub-aortic stenosis,”
nd 58 procedures were excluded from one site with unacceptable
ortality data, resulting in 409,524 procedures in the study. An
dditional 424 were missing gender information, leaving 409,100
or inclusion in the statistical model. The individual procedures
nd sample sizes are shown in Table 1. The most common oper-
tions were isolated aortic valve procedures (n  216,245), fol-
owed by mitral valve procedures (n  132,641) and then aortic-
itral double-valve (n  24,607), aortic root replacement (n 
1,545), and mitral-tricuspid double-valve (n  11,532) opera-
ions. There were 3121 aortic-mitral-tricuspid triple valves. The
ncidence of concomitant coronary bypass and “other” procedures
lso is shown. The types of “other” cases are shown in Table 2. In
eneral, these operations represent a small fraction of the overall
ABLE 1. Distribution of valve procedures
No.
% Concomitant Unadjusted
mortalityCAB “Other”
ingle valve
A 216,245 50.0% 11.7% 5.7%
M 132,641 44.8% 11.6% 7.7%
T 3688 20.5% 41.9% 10.7%
P 819 16.1% 41.1% 4.4%
R 11,545 20.9% 64.5% 11.1%
ouble valve
A, M 24,608 38.3% 13.0% 11.5%
A, T 1183 29.6% 24.8% 14.0%
A, P 2574 10.2% 25.0% 3.1%
M, T 11,532 29.0% 23.4% 10.8%
M, P 43 27.9% 16.3% 9.3%
R, M 729 31.1% 52.3% 17.4%
T, P 186 9.1% 50.0% 6.0%
R, T 69 20.3% 40.6% 18.8%
R, P 248 10.9% 43.5% 2.8%
riple valve
A, M, T 3121 27.1% 20.5% 15.3%
A, M, P 92 20.7% 18.5% 5.4%
A, T, P 23 17.4% 26.1% 4.4%
M, T, P 33 39.4% 24.2% 9.1%
R, M, T 87 25.3% 49.4% 23.0%
R, M, P 6 0.0% 16.7% 0.0%
R, T, P 3 33.3% 33.3% 66.7%
uadruple valve
A, M, T, P 47 61.7% 27.7% 8.5%
R, M, T, P 2 0.0% 50.0% 100.0%
otal 409,524
AB, Coronary artery bypass; A, aortic valve; M, mitral valve; T, tricuspid
alve; P, pulmonic valve; R, aortic root reconstruction.roup and are composed of highly diverse populations. Ablation
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CDrocedures for atrial fibrillation were not recorded until recently
nd are omitted. Baseline characteristics of the overall series are
resented in Table 3. Preoperative variables remained fairly con-
tant over the decade, except that obesity increased from 6% to
1%, diabetes increased from 17% to 23%, hypertension increased
rom 46% to 66%, cerebrovascular disease increased from 8% to
5%, and minor increases were observed in age (65.1 years to 66.3
ears, mean), peripheral vascular disease (9% to 13%), and renal
ailure (6% to 8%). Because this study also focused on elective
ersus acute presentation, baseline data are given additionally for
hese subgroups.
election of Variables for Analysis
n order to compare quantitatively the relative importance of
reoperative patient characteristics in the risk factor analysis,
ariables were simplified as much as possible and, except for
umber of comorbidities, were dichotomized so that each could be
valuated as a single degree of freedom. Decisions in this process
ere made prospectively before the analysis began and were
nfluenced by perceived clinical relevance and the results of pre-
ious similar clinical research. The risk factors that were selected
ncluded the following: acute presentation (nonelective vs elec-
ive); age (70 years vs70 years); reoperation (yes/no); etiology
ndocarditis (yes/no); presence of coronary disease, performance
f coronary bypass (yes-no); the decision for valve replacement
ersus repair (for multiple valves, any valve repaired  repair
roup); New York Heart Association class III or IV congestive
eart failure preoperatively (yes/no); gender (female vs male);
evere LV dysfunction (ejection fraction 0.35 vs 0.35); earlier
ear of operation (first 5-year period vs second 5-year period);
resence and number of comorbidities (range, 0-10); hemodynam-
cally severe valve lesion (vs mild to moderate); and valve proce-
ABLE 2. Concurrent nonvalvular procedures
Procedure No.
AICD 366
ASD 6188
Batista 172
Congenital 2410
Heart transplantation 130
LVA 1587
TMR 321
Pacemaker 2031
SVR 178
Cardiac trauma 212
VSD 1033
Ascending aortic replacement 19,143
Carotid endarterectomy 2257
Other, thoracic 1932
Other, vascular 3134
Other, cardiac 19,386
ICD, Automatic internal cardiac defibrillator; ASD, atrial septal defect
losure; LVA, left ventricular aneurysm resection; TMR, transmyocardial
evascularization; SVR, surgical ventricular restoration; VSD, ventricular
eptal defect closure.ure required (referenced to single aortic valve repair or replace- l
The Journal of Thoracicent procedure): aortic root reconstruction, tricuspid valve
rocedure, multiple valve procedure (2 valves operated), mitral
alve procedure, pulmonic valve procedure, valve plus other major
peration (eg, ascending aortic replacement, LV aneurysm resec-
ion, and septal defect closure; see Table 2), and aortic valve
rocedure. There were 303,043 procedures in the elective group,
nd the nonelective (acute presentation) group contained 106,481
ivided into 3 categories: urgent (n  90,956), emergency (n 
2,867), and salvage (n  2658). The current STS operational
efinition of urgent status is as follows: “All of the following
onditions are met: Not elective status. Not emergency status.
rocedure required during same hospitalization in order to mini-
ize chance of further clinical deterioration. Worsening, sudden
hest pain, congestive heart failure, acute myocardial infarction,
recarious anatomy, IABP, unstable angina with intravenous ni-
roglycerin or rest angina may be included.” The definition for
mergency is as follows: “The patient’s clinical status includes any
f the following: Ischemic dysfunction: 1. Ongoing ischemia in-
luding resting angina despite maximal medical therapy (medical
nd/or IABP); 2. Acute evolving myocardial infarction within 24
ours before surgery; or 3. Pulmonary edema requiring intubation.
echanical dysfunction (either of the following): 1. Shock with
irculatory support; or 2. Shock without circulatory support.” The
efinition for salvage is as follows: “The patient was undergoing
ardiopulmonary resuscitation en route to the operating room or
rior to anesthesia induction.” The STS definition for mortality is
eath during the same hospitalization as the valve surgery or after
ischarge but within 30 days of the operation. Again, other defi-
itions are given at http://www.sts.org. In the analysis, comorbidi-
ies included morbid obesity (body mass index 35), smoker,
iabetes, renal failure, dialysis, hypertension, hyperlipidemia, im-
unosuppressive therapy, cerebrovascular disease, and peripheral
ascular disease. Missing categoric variables were imputed by
ssigning the modal value, and missing continuous variables were
ssigned the median value. Again, less than 5% of data were
issing overall.
tatistical Analysis
multivariable logistic regression model was used to quantify the
ssociation between each explanatory variable and operative mor-
ality in a manner that partially adjusted for the confounding
ffects of other variables. The form of the logistic regression
quation was as follows:
log i1 i   x′i  ,
here i is the probability of mortality for the ith patient,  is the
odel intercept term,  is the vector of regression parameters, and
i is the vector of explanatory variables for the ith patient. This
ype of logistic methodology has been shown to be superior to
ther techniques for the purpose of risk factor analysis.5,6 The
agnitude of the effect of each explanatory variable in the logistic
odel was quantified by using 2 statistics: the odds ratio (OR) and
he adjusted mortality difference. The latter is defined as the
ifference between the average predicted risk of mortality in the
tudy population if each subject had the risk factor in question
inus the average predicted risk of mortality in the study popu-ation if no subject had the risk factor in question, holding all other
and Cardiovascular Surgery ● Volume 131, Number 3 549
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A
CDABLE 3. Baseline patient characteristics
Variable Overall Elective Nonelective P value
No. 409,524 303,043 106,481
Age (y) .0001
Mean 66.1 65.7 67.4
Median 69.0 69.0 70.0
Age 70 y 48% 47% 53% .0001
Gender .0001
Male 57% 57% 56%
Female 43% 43% 44%
Race .0001
White 87% 87% 85%
Black 5% 5% 6%
Other-unknown 8% 8% 8%
No. of comorbidities .0001
0 13% 14% 10%
1 26% 27% 22%
2 27% 27% 26%
3 19% 18% 20%
4 10% 9% 12%
Obesity (BMI 35) 9% 9% 9% .2706
Smoker 48% 48% 50% .0001
Current smoker 14% 13% 16% .0001
Diabetes 20% 18% 25% .0001
Hyperlipidemia 37% 36% 38% .0001
Renal failure 7% 5% 12% .0001
Dialysis-dependent RF 2% 1% 3% .0001
Last creatinine preoperatively .0001
Mean 1.3 1.2 1.5
Median 1.0 1.0 1.1
Hypertension 58% 56% 62% .0001
CVA 8% 7% 10% .0001
COPD 13% 12% 17% .0001
Immunosuppressive treatment 3% 2% 4% .0001
PVD 12% 11% 16% .0001
CVD 12% 11% 15% .0001
Prior MI 19% 15% 31% .0001
MI within 7 d 5% 2% 13%
MI within 8-21 d 2% 1% 4%
MI within 21 d 11% 11% 13%
Reoperation 19% 18% 21% .0001
Prior PCI 7% 6% 9% .0001
Endocarditis 5% 4% 9% .0001
Any severe lesion 79% 80% 75% .0001
NYHA class .0001
I 10% 11% 7%
II 18% 21% 10%
III 39% 41% 33%
IV 21% 14% 40%
CHF 34% 29% 49% .0001
Angina type .0001
No angina 63% 66% 53%
Stable 22% 24% 18%
Unstable 15% 10% 29%Cardiogenic shock 3% 1% 9% .0001
50 The Journal of Thoracic and Cardiovascular Surgery ● March 2006
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CDariables constant. Independent effects of individual variables on
ortality were assessed by comparing ORs. To examine differ-
nces in patient characteristics between elective and acute presen-
ation groups, 2 statistics were used for categoric variables, and
ilcoxon rank sum statistics were used for continuous variables.
ll analyses were performed with SAS version 8.2 software.
esults
aw unadjusted mortality rates for each of the procedures
re listed in Table 1. Table 3 shows patient characteristics in
he overall group and also for the elective and acute pre-
entation subgroups. In general, acute patients had a higher
ncidence of adverse risk factors and, overall, were sicker on
dmission. In Table 4 outcome variables are presented in 3
ays. First, unadjusted mortality rates are given for each
ubpopulation defined by the explanatory variables. The
ABLE 3. Continued
ariable Overall
esuscitation 1%
rrhythmia 27%
cuity of presentation
Elective 74%
Urgent 22%
Emergency 3%
Salvage 1%
A mean pressure
Mean 25.5
Median 24.0
ulmonary hypertension 12%
jection fraction
Mean 0.51
Median 0.50
jection fraction 0.35 89%
o. of diseased vessels
0 53%
1 13%
2 13%
3 21%
eft main disease 7%
ny valve replaced 81%
solated valve procedure
Aortic 53%
Mitral 32%
Tricuspid 0.90%
Pulmonic 0.20%
ortic root reconstruction 3%
ultiple valve procedure 10.89%
oncurrent CAB 46%
oncurrent non-CAB
procedure
14%
MI, Body mass index; RF, renal failure; CVA, cerebral vascular accident; C
VD, cerebral vascular disease; MI, myocardial infarction; PCI, percutaneo
eart failure; PA, pulmonary artery; CAB, coronary artery bypass.nivariable magnitude of effect of a given risk factor on raw i
The Journal of Thoracicortality is evident. Then adjusted mortality differences are
resented, examining the effect of the variable under con-
ideration, with the others held fixed. This is important, for
xample, because one variable (eg, acute presentation) often
s associated with a higher incidence of other adverse risk
actors, such as advanced age or comorbidities. Finally, the
Rs quantify the relative effects of each independent vari-
ble on mortality within the multivariable logistic regres-
ion model. With the large sample size, virtually all vari-
bles are highly statistically significant, but using adjusted
isk differences and ORs, relative magnitudes are more
asily assessed. The C statistic of the model was 0.735,
ndicating high predictive power.
Of baseline characteristics, acute presentation proved to
e the most important determinant of mortality, and the
Elective Nonelective P value
0% 3% .0001
26% 30% .0001
.0001
100% 0%
0% 85%
0% 12%
0% 2%
.0001
24.5 28.0
24.0 27.0
11% 16% .0001
.0001
0.52 0.48
0.50 0.50
91% 83% .0001
.0001
56% 42%
13% 12%
13% 15%
18% 30%
5% 11% .0001
82% 79% .0001
54% 49% .0001
31% 35% .0001
0.87% 1.00% .0001
0.23% 0.11% .0001
2% 4% .0001
10.76% 11.24% .0001
42% 56% .0001
13% 17% .0001
chronic obstructive pulmonary disease; PVD, peripheral vascular disease;
ronary intervention; NYHA, New York Heart Association; CHF, congestiveOPD,
us concidence appeared to accelerate over time (Figure 1). Acute
and Cardiovascular Surgery ● Volume 131, Number 3 551
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CDresentation was present in 22.4% of procedures in 1994
ersus 31.7% in 2003 (a 42% increase over the decade). To
llustrate the effects of acute presentation on mortality, the
aw elective mortality was 5.1% versus 12.9% for acute
resentation (a 253% increment). Within acute categories,
he raw mortality for urgent status was 10.4%, for emer-
ency status was 23.8%, and for salvage status was 44.8%.
he next most important variable was advanced age, fol-
owed by reoperation, endocarditis, etc. (listed in descend-
ABLE 4. Effects of baseline variables on outcome
ariable
Unadjusted
mortality
(%)
Unadjusted
mortality
difference
Adjust
mortal
(%)
cute presentation 12.9 — 10.7
lective 5.1 7.8 5.5
ge 70 y 9.4 — 9.1
ge 70 y 5.0 4.4 5.2
eoperation, yes 11.3 — 9.7
eoperation, no 6.2 5.1 6.4
ndocarditis, yes 10.6 — 10.3
ndocarditis, no 6.9 3.7 7.0
AD, yes 9.3 — 8.4
AD, no 5.0 4.3 5.6
alve replacement 7.2 — 7.4
alve repair 6.8 0.4 5.1
HF, yes 10.5 — 8.3
HF, no 5.4 5.1 6.3
emale gender 8.4 — 8.3
ale gender 6.2 2.2 6.3
F 0.35 6.6 — 6.9
F 0.35 11.1 4.5 8.9
ear 1999 6.9 — 6.4
ear 1999 7.5 0.6 8.3
Comorbidities 4.5 — 5.0
Comorbidity 5.5 1.0 5.8
Comorbidities 6.4 1.9 6.8
Comorbidities 8.1 3.6 7.9
Comorbidities 10.5 6.0 9.1
evere Lesion, yes 6.8 — 6.9
evere Lesion, no 8.4 1.6 8.1
verall 7.1 — 7.1
rocedures (referenced to AVR)
Aortic root 11.1 5.4 13.5
Isolated tricuspid 10.7 5.0 11.4
Multiple valve 11.2 5.5 10.5
Isolated mitral 7.7 2.0 7.9
Isolated pulmonic 4.4 1.3 7.1
Isolated aortic 5.7 — 5.6
Concurrent operation, yes 10.0 — 9.9
Concurrent operation, no
(referenced to valve-only
procedure)
6.7 3.3 6.7
he regression intercept was 4.3817. CAD, Coronary artery disease; CHFng order in Table 1). Patients selected for valve repair t
52 The Journal of Thoracic and Cardiovascular Surgery ● Marcenerally had better survival than those receiving replace-
ent, and female gender was associated with a higher
ortality. Operative results appeared to improve over time,
nd although the average effect of a single comorbidity was
odest, multiple morbidities or specific morbidities, such as
enal failure, could produce major effects. Having a hemo-
ynamically severe valve lesion seemed to be protective.
With regard to individual procedures, aortic root recon-
truction appeared to have the highest risk, followed by
Adjusted
mortality
ifference Adjusted odds ratio 2
Parameter
estimate P value
— 2.11 3244 0.7445 .001
5.2
— 1.88 2150 0.6322 .001
3.9
— 1.61 1123 0.4762 .001
3.3
— 1.59 338 0.4614 .001
3.3
— 1.58 1024 0.4552 .001
2.8
— 1.52 408 0.4158 .001
2.3
— 1.39 605 0.3262 .001
2.0
— 1.37 590 0.3139 .001
1.9
— 1.34 280 0.2944 .001
2.0
— 1.34 511 0.2945 .001
1.9
— 1.19 1586 0.1716 .001
0.8 (Average per comorbidity)
1.8
2.9
4.1
— 0.83 151 0.1880 .001
1.2
—
7.9 2.78 650 1.0227 .001
5.8 2.26 199 0.8173 .001
4.9 2.06 1440 0.7203 .001
2.3 1.47 578 0.3880 .001
1.5 1.29 2 0.2556 .141
— 1.00 — — —
— 1.58 736 0.4568 .001
3.2
gestive heart failure; EF, ejection fraction; AVR, aortic valve replacement.ed
ity
dricuspid valve procedures and multiple valve procedures,
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CDtc. (Table 1). The ORs in this analysis are referenced to the
owest-risk operation, aortic valve procedures. Focusing on
oot reconstructions (n  11,545), 10,724 were listed as
aving valve conduits, and 821 had valve-sparing root re-
lacements. Of the entire group, 6044 (52%) were per-
ormed for ascending aortic aneurysms, 435 (4%) for aortic
issections, and 5066 (44%) had no aortic root pathology
ocumented. The majority of the latter group was listed as
aving aortic stenosis (42.3%) and/or aortic insufficiency
50.7%) only. In the latter group 2152 patients had stentless
orcine or homograft root replacement, 545 had mechanical
alve composite grafts, and the remainder had a plethora of
ther prostheses. The raw mortality for root reconstruction
or aortic aneurysms was 10.5%, for aortic dissection was
3.7%, and for root replacement without root pathology was
.5%. In the valve plus “other” category, 9877 patients had
ortic valve and noncomposite ascending aortic replacement
rocedures, with a raw mortality of 9.2%. In the entire data
et, addition of an “other” cardiac or noncardiac operation
ncreased average risk appreciably (Table 1), although there
as likely significant variation between “other” categories
Table 2). In the “other” analysis, the OR was referenced to
he same valve procedure but without the “other” compo-
ent. Lastly, the primary causes of death for the study group
re shown in Table 5. This primary designation refers to the
ingle problem that initiated the fatal outcome, understand-
ng that additional problems likely occurred during the
ospital course. The most important initiating factor was
ardiac, followed by pulmonary and neurologic, as listed in
able 5. Also documented are the incidences of complica-
ions occurring in the data set. Atrial fibrillation was most
ommon, followed by pulmonary and renal complications,
nd the remainder are shown in Table 5. In this analysis
igure 1. The incidence of acute presentation increased steadily
ver the decade.atients could have more than one complication. s
The Journal of Thoraciciscussion
mprovements in cardiac surgery over the past half century
t times have been rapid and at others have been slow and
ncremental. It is reasonable to state, however, that the
urrent aggregate ability to surgically manage heart disease
as been one of the medical success stories of all time. The
rst step in quality improvement is defining a problem area,
hich requires data collection and analysis, and then strat-
gies are implemented to overcome specific deficiencies.7
s a final step, data again are collected to verify the efficacy
f therapeutic interventions. Cardiac valve surgery presents
pecial difficulties in following this process. Most studies
rom single centers have evaluated small series of patients
nd focused on highly specific subgroups. Often, a center
s motivated to publish only good results, so that problem
reas can be overlooked. Because outcomes can represent a
oving target, assessment over time is important, and con-
usion has existed regarding patient classification in some
ategories. Adverse characteristics, such as advanced age,
ow ejection fraction, hemodynamic severity, and acute
resentation, probably affect prognosis more than in coro-
ary surgery,8 but the exact magnitudes are unclear. This
ABLE 5. Causes of mortality and morbidity
Primary cause of mortality
Cardiac 60.3%
Pulmonary 8.9%
Neurologic 8.2%
Infection 6.4%
Renal 3.3%
Vascular 2.0%
Valvular 1.1%
“Other” 9.8%
Complications
Atrial fibrillation 27.0%
Prolonged ventilation 14.0%
Renal failure 7.1%
Reoperation for bleeding 5.5%
Heart block 5.2%
Pneumonia 4.5%
Gastrointestinal 4.3%
Noncardiac reoperation 3.5%
Cardiac arrest 3.3%
“Other” cardiac reoperation 3.1%
Urinary tract infection 2.9%
Permanent stroke 2.8%
Septicemia 2.5%
Multiorgan failure 2.1%
Anticoagulation complication 2.0%
Transient stroke 1.5%
Tamponade 1.4%
Coma 24 h 1.1%
Leg infection 1.0%
ther complications occurred in less than 1.0%.tudy was designed to evaluate comprehensively the mor-
and Cardiovascular Surgery ● Volume 131, Number 3 553
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A
CDality characteristics of the entire STS valve surgery data-
ase over the past 10 years and potentially to overcome
any of the methodologic deficiencies outlined above. The
verall goal was to define current problem areas in valve
urgery for future innovation and quality improvement. A
econdary goal was to better understand how variables
nterrelate to produce an overall mortality figure.
The most striking problem area in the current analysis
as acute presentation. Similar to other studies and with all
ther variables being constant, acute presentation was asso-
iated with a 2-fold increase in operative mortality, which
as more than any other risk factor.9-12 Less than a quarter
ere “obligatory” emergencies (eg, acute myocardial in-
arction, endocarditis, and aortic dissection), so that most
ight have been candidates for earlier intervention. Al-
hough definitive conclusions about the timing of the oper-
tion are difficult to make from data such as these, it is
lausible that referring patients with significant valve le-
ions under elective conditions before severe refractory
ymptoms convert the operation to urgent status could affect
verall operative mortality in a positive manner. It is dis-
oncerting that the incidence of acute presentation increased
y 42% over the decade. One could hypothesize that cardi-
logy practice has preferentially emphasized acute coronary
isease during this period, and perhaps some of this acute
ocus has carried over to valvular patients. On the other
and, the concept of earlier referral is now well accepted for
itral regurgitation, and perhaps with documentation of
cute presentation risks, a similar principle could be estab-
ished for all of valve surgery. The best results are obtained
ith elective referral, and procrastinating until urgent or
mergency intervention is required seems to double opera-
ive risk.
The other surprising finding of this study was the high
elative risk of aortic root replacement. It appeared that this
as not due to a predominance of aortic dissections in the
opulation (mortality, 23.7%) because dissection comprised
nly 4% of cases. Although composite aortic valve and
scending aortic replacement for root aneurysm was asso-
iated with a 10.5% mortality and noncomposite replace-
ent had a 9.2% mortality, all of these results might not be
ut of line.13-15 The high mortality for root replacement for
tandard aortic valve disease without root pathology, how-
ver, deserves special attention. It seemed that almost half
f the aortic root reconstructions were performed in the
bsence of aneurysms, and this might reflect the recent trend
oward using freestyle or homograft prostheses as root re-
lacements for isolated aortic valve disease. Although this
roup comprised less than 3% of aortic valve procedures
without root pathology), the mortality was close to 10%. It
hould be emphasized that simple aortic valve replacement
n this series was the lowest-risk valve surgery (5.7% raw
ortality) and that standard valve replacement probably r
54 The Journal of Thoracic and Cardiovascular Surgery ● Marchould be used preferentially when the root is normal. In
act, most authorities would agree that root replacement
hould be reserved for patients with complex dissections,
nnuloaortic ectasia, or true root aneurysms,14,15 and the
rend toward inappropriate root replacement should be
iscouraged.
To experienced valve surgeons, it is not surprising that
solated tricuspid valve procedures carried such a high risk.
hese patients often present with advanced sequelae of
hronic systemic venous hypertension, such as liver or renal
ailure, and can pose difficult management problems. The
ffects of chronic tricuspid regurgitation can be subtle and
nsidious, and a message of careful monitoring and early
eferral for this disorder also would be appropriate. Usually,
n any single center only a small number of isolated tricus-
id procedures are available for analysis, and this group
epresents one example for which the STS data set could be
seful. It is clear from this study that isolated tricuspid
rocedures constitute one of the high-risk categories. Mul-
iple valve surgery also is a complex topic.16 Each of the
ifferent valve combinations likely represents differing pa-
hologies; for example, the aortic-pulmonic valve proce-
ures might be predominantly Ross operations. With such a
arge number of multiple valve procedures, the STS registry
ight be uniquely positioned to better understand this di-
erse topic, and more detailed analyses seem indicated.
This study produced many more questions than it an-
wered. The risk of advanced age is ubiquitous in surgical
rticles,11,17-19 but the importance of reoperation recently
as been de-emphasized.9,20-22 As the third most important
reoperative variable over the past decade, reoperation cer-
ainly deserves more careful examination. Perhaps reopera-
ion is of minimal importance for simple isolated procedures,
ut with more complex lesions (that are less frequently
eported), the risk is amplified. Reoperation could be a
ruitful topic for future study, including formal analysis of
tatistical interactions of variables. Similarly, the topics of
ndocarditis and valve repair versus replacement should be
urther investigated, as well as that of female gender. As in
ther studies,23-26 coronary disease and LV dysfunction
ncreased risk.
Similar to previous analyses,27 adjusted mortality de-
reased by almost 25% over the decade, almost certainly
ecause of refinements in surgical technique and postoper-
tive care. Was this a general phenomenon or a specific
unction of certain procedures? Did the emergence of min-
mally invasive valve surgery or the increasing use of valve
epair contribute to this effect?28-32 Parenthetically, and
erhaps disturbingly, unadjusted mortality decreased by
nly 8%. The difference was largely due to increased rates
f acute presentation, and reversal of the acute presentation
rend could allow relative improvements in valve surgery
esults to become more evident in everyday practice. Co-
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A
CDorbidity effects in this study were assessed in a fairly
udimentary way. It would be useful to apply a weighted
omorbidity index to take into account the more pronounced
ffects of certain comorbidities, such as renal failure.33
inally, hemodynamically severe valve lesions seemed to
ave a protective effect on operative mortality. Perhaps this
nding is a function of immediate and profound hemody-
amic improvement postoperatively, although again, further
nalysis will be required to clarify this point.
One function of a database is to define problem areas so
hat potential solutions can be considered. It is interesting
hat cardiac issues remain the initiators of mortality in more
han half of operative deaths. Although the exact types of
ardiac problems are not documented, one can surmise that
ow cardiac output or other manifestations of inadequate
yocardial protection might still be occurring in some
omplex valve cases requiring longer clamp times. Cardiac
rrhythmias also might be contributing to mortality and
onstitute the most common complication. Lastly, pulmo-
ary problems remain the most frequent noncardiac cause of
orbidity and mortality,34,35 and effective innovations in
ach of these areas will likely produce further improve-
ents in the future.
This attempt at a comprehensive analysis of overall valve
urgery mortality should not be construed as a substitute for
etailed assessment of individual procedures. Rather, this
tudy poses a different question: What are the aggregate risk
actors for all types of valve surgery? With current trends
oward publication of overall valve mortality figures from
enter to center, an improved general understanding of
elationships between baseline risk and mortality will be
mportant.36 Especially because baseline characteristics in-
uence valve mortality to a greater extent than coronary
urgery, further illumination seems indicated. This study
an be viewed as a first draft of such an analysis and
roduced several surprising results. Each of these findings,
owever, is dependent on the quality of data recording, and
oding errors are possible, even though many audits have
hown STS data to be very accurate. Other limitations of the
ata set exist, such as the 5% of patients listed as having
other” cardiac procedures, the exact nature of which is
nknown. Each of these issues is being addressed, and
opefully, the STS database will continue as a prime exam-
le of physician-initiated evidence-based medicine.
In conclusion, this study illustrates the power of multi-
enter collaboration in generating a clinical database in
dult cardiac surgery. Complex or unusual valve procedures
an be investigated in a valid and comprehensive manner,
nd concepts can be developed that are difficult to perceive
n any single center. A major finding of this study was the
igh mortality in possibly inappropriate aortic root recon-
tructions. The data suggest that simple aortic valve replace-
ent (the lowest-risk procedure) should be favored for all
The Journal of Thoracicut the most compelling aortic root pathology. Finally, the
ost important observations of this study are the accelerat-
ng trend toward acute presentation over the past decade and
he primary importance of this variable in increasing oper-
tive risk. Cardiac clinicians should redouble their efforts to
mphasize earlier surgical referral for all types of severe
alve lesions before urgent or emergency intervention is
equired.
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iscussion
r James I. Fann (Stanford, Calif). Scott, you and your col-
eagues have performed a comprehensive analysis of the determi-
ants of operative mortality in patients undergoing valve surgery
sing what has become a tremendous resource, the STS database.
he importance of this study is that it is an unbiased look at a
roup of more than 400,000 patients over a 10-year period. Al-
hough this is a retrospective analysis and in a somewhat selected
roup of patients, it is perhaps the most reliable statistical analysis
o date directed at independent risk factors in patients undergoing
alve surgery. As you mentioned, this analysis is important be-
ause it is not subject to sampling bias or the results of a single
enter or surgeon. It does not focus on one specific procedure and
s not compiled over an inordinately long period of time.
In this study acute presentation was the most important risk
actor for operative mortality. This variable is well recognized in
ts association with a worse outcome, and you mentioned that it is
mportant to refer patients with severe valve lesions under elective
nd not emergency conditions. What is more important is the t
56 The Journal of Thoracic and Cardiovascular Surgery ● Marcnderlying problem that caused the patient to present acutely. My
rst question is this: How did these acute or emergency patients
resent? As background, I notice that 14% of the patients in the
cute category were operated on for emergency or salvage indica-
ions, whereas the other 85% were in the urgent subgroup. Were
he emergency and salvage patients with operative mortality rates
f 24% and 45%, respectively, patients presenting with acute
yocardial infarction, congestive heart failure, and/or endocardi-
is, because these are significant risk factors that you mentioned,
nd they also are variables that might not be directly affected by
arlier valvular intervention?
Dr Rankin. Thank you, Jim, and I would like to also first
ecognize the many individuals who have contributed to the de-
elopment of the STS database, many of whom are in this room.
s you said, this has become an important resource for all of us;
t was quite a good idea.
It is clear that the acute presentation group is a heterogeneous
roup, and there are patients with, let us say, obligatory acute
resentation (eg, aortic dissections and endocarditis) that are at
igher risk and require operations with no opportunity for inter-
ention. But if we look at the overall numbers of those patients,
hey are the minority, accounting for less than a fourth of the
opulation. The majority of patients are potential candidates for
arlier referral. If we correlate to our own clinical practices, I think
e have seen in recent years that patients are being referred later,
erhaps “worked up a year ago, decided against surgery,” and then
year later, all of a sudden they are in the hospital with pulmonary
dema requiring an emergency operation. Therefore I think there is
robably a definite majority of the acute presentation patients who
ight have been evaluated earlier and perhaps could have been
perated on earlier. It has been so successful in mitral valve repair
o convince the cardiologists to refer the patients earlier, and
arlier referral has really improved the outcomes. I think we now
eed to extend that concept to all of valvular surgery: if a patient
as a severe valve lesion, there is really no advantage to waiting.
Dr Fann. Just as interesting is your finding that aortic root
econstruction was the highest-risk procedure, with an OR of more
han 2.7 referenced to aortic valve replacement. What is important
o realize is that in this group, 5066 patients had no aortic root
athology, and more than 2100 of them had a stentless porcine or
omograft root replacement. The mortality for reconstruction with-
ut root pathology is more than 9%. Your conclusion that root
eplacement should be considered only for specific root pathology
eeds to be emphasized. There are numerous reports of substan-
ially lower operative mortality rates than what was found in the
eries of patients undergoing stentless valve implant. Why do you
hink that the operative mortality rate in this group is so much higher
han the rate that has been reported, other than a mere reality check?
Dr Rankin. I think it is also important to emphasize that there
s no such thing as perfect methodology in clinical research. In
ome ways, if I present a series of 120 mitral valve repairs,
dvantages exist, because I took care of all those patients. I really
new everything that happened with them, but the disadvantage is
he small sample size. Here we have the opposite extreme, a large
ample size as an advantage but a large distance from these
atients as a disadvantage, and we do not quite understand what
as going on with all of them or what the exact pathology was. Buthere is a definite suggestion in these data that there are a lot of
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CDatients now undergoing root replacement with no root pathology,
nd I think this correlates with some of the articles describing
reestyle root replacement as a routine. The STS data suggest that,
n the national data set with the real world of all the surgeons doing
his in the country, the mortality with this approach is higher than
e might think. Given this information, it seems prudent to con-
ider going back to performing just simple aortic valve replace-
ent in these patients.
Dr Fann. Reoperation was a risk factor for operative mortality,
ith an OR of 1.61. Interestingly, it also comprised a statistically
igher proportion of patients in the nonelective category. One
uestion is, how do you define reoperation? Is it redo sternotomy
r reoperation for a degenerated or otherwise dysfunctional valve?
f it is the latter, and based on the data presented, do you personally
hink that the argument for placing a bioprosthesis to avoid thrombo-
mbolic and anticoagulation-related complications in the younger
atient with the intention of future reoperation is justified?
Dr Rankin. Well, I will go back to say that we are in the early
tages of looking at the entire data set, and it was a bit of a surprise
o us to see that reoperation was so important. I would suggest that
ny of you who are interested turn in a proposal to the STS
ublications committee to study the reoperation factor as deter-
ining operative mortality—we need to get into those data more.
he definition was any previous sternotomy, coronary bypass or
alve. Now this finding does not correlate well with all of our
rticles in the current literature examining isolated aortic or mitral
alve procedures in which reoperation is no longer a risk factor.
y personal bias is that the reoperation risk probably is relatedinterest when they agree to review a manuscript.
The Journal of Thoracicomes much more important when we get into the more complex
perations. I think this is something that needs to be addressed.
Dr Fann. One group of patients that warrants further investi-
ation is comprised of those who underwent mitral valve proce-
ures. Dr Glower and you have previously reported that survival
fter mitral valve repair for ischemic mitral regurgitation is more
nfluenced by patient characteristics and comorbidity than by the
schemic cause of mitral regurgitation. What was important in that
tudy was the consistent surgical techniques and the undersizing of
he annuloplasty ring. In the current study the presence of coronary
rtery disease was a significant independent risk factor for opera-
ive mortality. Do you think that this finding is suggestive that patients
ho undergo surgical intervention for ischemic mitral regurgitation
o worse in terms of operative outcome regardless of comorbidity?
Dr Rankin. One of the problems in the STS data set is that
here are a handful of definitions that are lacking. For example,
ause of valve disease is not recorded, and therefore it is difficult
o say much about ischemic mitral regurgitation. One thing that is
lear, however, from Don’s recent article, the recent Cleveland
linic article, and David Adams’ work is that the results with
outine repair in ischemic mitral regurgitation are a lot better now.
schemic cause, per se, is likely not a prominent risk factor. The
ther general impression that is evident in the national cardiac
urgery data set is that the quality of cardiac surgery throughout
he United States is at an extremely high level. If we look at
verage mortalities for any procedure and so on, they are only a
ouple points higher than the very best ones reported in the
iterature, and therefore I think we can all be proud of our specialtyore to the multiple valve procedures and that reoperation be- and what has happened over the past decades.
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